Page last updated: 2024-08-03 04:09:34

big gastrin

Description

big gastrin: isolated from Zollinger-Ellison syndrome gastrinomas & hog antral mucosa; have encountered tetratricontapeptide & nonadecapeptide gastrin; big-big gastrin significantly higher in patients with duodenal ulcers; big gastrin refers gastrin which has a longer peptide chain than the normal heptadecapeptide gastrin [MeSH]

Cross-References

ID SourceID
PubMed CID16132306
MeSH IDM0061679

Synonyms (11)

Synonym
big gastrin
53988-98-0
gastrin 34
g-34
gastrin 71
pro-gastrin
3bl184galn ,
gastrin 52
big-big gastrin
unii-3bl184galn
gastrin (human), big

Research

Studies (257)

TimeframeStudies, This Drug (%)All Drugs %
pre-199069 (26.85)18.7374
1990's79 (30.74)18.2507
2000's68 (26.46)29.6817
2010's30 (11.67)24.3611
2020's11 (4.28)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews20 (7.60%)6.00%
Case Studies1 (0.38%)4.05%
Observational0 (0.00%)0.25%
Other242 (92.02%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
phosphoserinenon-proteinogenic alpha-amino acid;
O-phosphoamino acid;
serine derivative
human metabolite2011201113.0low000010
carbamatesamino-acid anion2006200618.0low000100
hydrochloric acidchlorine molecular entity;
gas molecular entity;
hydrogen halide;
mononuclear parent hydride
mouse metabolite1995199529.0low001000
glycinealpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid
EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical
1985200530.2low043200
histaminearalkylamino compound;
imidazoles
human metabolite;
mouse metabolite;
neurotransmitter
1995199529.0low002000
hydrogenelemental hydrogen;
elemental molecule;
gas molecular entity
antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
2001200123.0low000100
tyrphostin ag 1024alkylbenzene2013201311.0low000010
chlorpromazineorganochlorine compound;
phenothiazines;
tertiary amine
anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug
2012201212.0low000010
cimetidinealiphatic sulfide;
guanidines;
imidazoles;
nitrile
adjuvant;
analgesic;
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
1985198539.0low010000
ciprofibratecyclopropanes;
monocarboxylic acid;
organochlorine compound
antilipemic drug2004200420.0low000100
clofibratearomatic ether;
ethyl ester;
monochlorobenzenes
anticholesteremic drug;
antilipemic drug;
geroprotector;
PPARalpha agonist
2004200420.0low000100
clofibric acidaromatic ether;
monocarboxylic acid;
monochlorobenzenes
anticholesteremic drug;
antilipemic drug;
antineoplastic agent;
herbicide;
marine xenobiotic metabolite;
PPARalpha agonist
2004200420.0low000100
deferoxamineacyclic desferrioxaminebacterial metabolite;
ferroptosis inhibitor;
iron chelator;
siderophore
2010201014.0low000100
fenofibratearomatic ether;
chlorobenzophenone;
isopropyl ester;
monochlorobenzenes
antilipemic drug;
environmental contaminant;
geroprotector;
xenobiotic
2004200420.0low000100
gemfibrozilaromatic etherantilipemic drug2004200420.0low000100
metronidazoleC-nitro compound;
imidazoles;
primary alcohol
antiamoebic agent;
antibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
environmental contaminant;
prodrug;
radiosensitizing agent;
xenobiotic
1993199331.0low001000
omeprazolearomatic ether;
benzimidazoles;
pyridines;
sulfoxide
1992200427.8low007100
potassium chlorideinorganic chloride;
inorganic potassium salt;
potassium salt
fertilizer1996199628.0low001000
proglumidebenzamides;
dicarboxylic acid monoamide;
glutamine derivative;
racemate
anti-ulcer drug;
cholecystokinin antagonist;
cholinergic antagonist;
delta-opioid receptor agonist;
drug metabolite;
gastrointestinal drug;
opioid analgesic;
xenobiotic metabolite
1987198737.0low010000
rabeprazolebenzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
1993199530.0low002000
rofecoxibbutenolide;
sulfone
analgesic;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
2003200321.0low000100
pirinixic acidaryl sulfide;
organochlorine compound;
pyrimidines
2004200420.0low000100
reserpinealkaloid ester;
methyl ester;
yohimban alkaloid
adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic
1997200125.0low001100
alaninealanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid
EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
2008200816.0low000100
serineL-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2011201113.0low000010
lysineaspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid
algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1995199529.0low002000
aminopyrinepyrazolone;
tertiary amino compound
antipyretic;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1987199533.0low011000
bromodeoxyuridinepyrimidine 2'-deoxyribonucleosideantimetabolite;
antineoplastic agent
1996200523.7low002100
levodopaamino acid zwitterion;
dopa;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid
allelochemical;
antidyskinesia agent;
antiparkinson drug;
dopaminergic agent;
hapten;
human metabolite;
mouse metabolite;
neurotoxin;
plant growth retardant;
plant metabolite;
prodrug
1997199727.0low001000
tyrosineamino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine
EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
1987200128.6low018200
methacholine chloridequaternary ammonium salt1988198836.0low010000
phenylalanineamino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
phenylalanine;
proteinogenic amino acid
algal metabolite;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
Escherichia coli metabolite;
human xenobiotic metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
2005200519.0low000100
cycloheximideantibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol
anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
2010201014.0low000100
mannitolmannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
2003200321.0low000100
argininearginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical
1995199529.0low001000
trifluoroacetic acidfluoroalkanoic acidhuman xenobiotic metabolite;
NMR chemical shift reference compound;
reagent
1981198143.0low010000
pyrrolidonecarboxylic acid5-oxoproline;
L-proline derivative;
non-proteinogenic L-alpha-amino acid
algal metabolite1983199535.0low011000
ditiocarbdithiocarbamic acidschelator;
copper chelator
1990199034.0low001000
cyclopentanecycloalkane;
cyclopentanes;
volatile organic compound
non-polar solvent1993199629.7low003000
deoxycytidinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2004200420.0low000100
goldcopper group element atom;
elemental gold
1985202026.7low020010
camptothecindelta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite
2003201017.5low000200
ammonium chlorideammonium salt;
inorganic chloride
ferroptosis inhibitor2001200123.0low000100
phosphotyrosineL-tyrosine derivative;
non-proteinogenic L-alpha-amino acid;
O(4)-phosphotyrosine
Escherichia coli metabolite;
immunogen
1991199133.0low001000
glutamic acidglutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical
2004200420.0low000100
azoxymethane2000201219.0low002310
bezafibratearomatic ether;
monocarboxylic acid amide;
monocarboxylic acid;
monochlorobenzenes
antilipemic drug;
environmental contaminant;
geroprotector;
xenobiotic
2004200420.0low000100
gemcitabineorganofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
2004200420.0low000100
adenosineadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
1996199628.0low001000
rosiglitazoneaminopyridine;
thiazolidinediones
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
insulin-sensitizing drug
2004200420.0low000100
cholecystokinin 33 (10-20)1986198638.0high010000
tyrosyl-glycyl-tryptophyl-methionyl-aspartyl-phenylalanyl-glycine1992200127.5high001100
docetaxel anhydroussecondary alpha-hydroxy ketone;
tetracyclic diterpenoid
antimalarial;
antineoplastic agent;
photosensitizing agent
2004200420.0low000100
sb 203580imidazoles;
monofluorobenzenes;
pyridines;
sulfoxide
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent
2010201014.0low000100
oxytocinheterodetic cyclic peptide;
peptide hormone
oxytocic;
vasodilator agent
1984198440.0low010000
devazepide1,4-benzodiazepinone;
indolecarboxamide
antineoplastic agent;
apoptosis inducer;
cholecystokinin antagonist;
gastrointestinal drug
2010201014.0low000100
enkephalin, leucinepentapeptide;
peptide zwitterion
analgesic;
delta-opioid receptor agonist;
human metabolite;
mu-opioid receptor agonist;
neurotransmitter;
rat metabolite
1984198440.0low010000
tyrosine o-sulfatearyl sulfate;
L-tyrosine derivative;
O-sulfoamino acid
human metabolite1991199531.0low002000
arginine vasopressinvasopressincardiovascular drug;
hematologic agent;
mitogen
1984198440.0low010000
curcuminaromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
2010201014.0low000100
boc-tyr(s03)-nle-gly-trp-nle-asp-2-phenylethyl ester2010201014.0low000100
brefeldin amacrolide antibioticPenicillium metabolite1993201025.8low003100
l 365260benzodiazepine1995201021.5low001100
neurokinin bpolypeptide1995199529.0low001000
bismuthmetal atom;
pnictogen
1993199331.0low001000
sulfurchalcogen;
nonmetal atom
macronutrient1996199628.0low001000
bafilomycin a1cyclic hemiketal;
macrolide antibiotic;
oxanes
apoptosis inducer;
autophagy inhibitor;
bacterial metabolite;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor;
ferroptosis inhibitor;
fungicide;
potassium ionophore;
toxin
1996199628.0low001000
abiraterone acetatepyridines;
sterol ester
antineoplastic agent;
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor;
prodrug
202320231.0low000001
sincalideoligopeptide1985201027.8low020200
pentagastrinorganic molecular entity2008201015.0low000200
calcimycinbenzoxazole1997199727.0low001000
pituitrin1984198440.0low010000
cholecystokinin1985201027.4low065700
ceruletideoligopeptidediagnostic agent;
gastrointestinal drug
2010201014.0low000100
gastrin heptadecapeptide, nle(15)-1995199529.0low001000
gastrins1980202226.7high0698766264
glucagonpeptide hormone1981201133.8low030010
somatostatin-281984198440.0low010000
gastrin 17gastrinantineoplastic agent1982201331.9medium02111720
bismuth subsalicylate1993199331.0low001000
neurotensinpeptide hormonehuman metabolite;
mitogen;
neurotransmitter;
vulnerary
2010201014.0low000100
interleukin-82003200321.0low000100
vasoactive intestinal peptide1981198143.0low010000
natriuretic peptide, brainpolypeptide2003200321.0low000100
neuromedin b1995199529.0low001000
tetracycline1993199331.0low001000
salicylatesmonohydroxybenzoateplant metabolite1993199331.0low001000
epidermal growth factor2000200024.0low001000
gastrin-releasing peptide1988201719.3low010110
cyclin d12003201116.3low000210
carboxypeptidase b1987198936.0low020000
gastrin i1985199434.5low011000
transforming growth factor alpha2000200521.5low001100
cholecystokinin 391989200129.0low010100
carbidopa1997199727.0low001000
preproenkephalin1984198440.0low010000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Aberrant Crypt Foci02012201212.0low000010
Achlorhydria01985200032.6low023000
Addison's Anemia01984199735.0low022000
Adenocarcinoma01984201724.0low013220
Adenocarcinoma, Basal Cell01984201724.0low013220
Adenoma01986201325.4low021110
Adenoma, Basal Cell01986201325.4low021110
Adenoma, beta-Cell01998199826.0low001000
Adenoma, Islet Cell01987198737.0low010000
Adenomatosis, Familial Endocrine01986198638.0low010000
Adenomatous Polyposis Coli02007201413.5low000110
Adenomatous Polyposis Coli, Familial02007201413.5low000110
Aggression02007200717.0low000100
Aging01986199333.5low013000
Androgen-Independent Prostatic Cancer0202320231.0low000002
Anesthesia02000200422.0low001100
Angiogenesis, Pathologic0201520159.0low000010
Anxiety02007200717.0low000100
Astrocytoma, Grade IV0202320231.0low000001
Benign Neoplasms0200620219.8low000211
Birth Weight01992199232.0low001000
Body Weight01993199331.0low001000
Breast Cancer0202320231.0low000001
Breast Neoplasms0202320231.0low000001
Cancer of Colon01992201720.0low007450
Cancer of Duodenum01989199532.0low011000
Cancer of Esophagus02008200816.0low000100
Cancer of Gastrointestinal Tract01999201118.8low001210
Cancer of Liver01986201726.3low031020
Cancer of Lung01988202312.2low021025
Cancer of Ovary01993199331.0low001000
Cancer of Pancreas01989200828.5low053400
Cancer of Parathyroid01986198638.0low010000
Cancer of Pituitary01987199533.0low011000
Cancer of Rectum01992199331.5low002000
Cancer of Stomach01984202221.4low012311
Carcinogenesis0201520178.0low000020
Carcinoma02000200123.5low001100
Carcinoma, Anaplastic02000200123.5low001100
Carcinoma, Bronchial01989198935.0low010000
Carcinoma, Bronchogenic01989198935.0low010000
Carcinoma, Epidermoid01998200821.0low001100
Carcinoma, Large Cell01998199826.0low001000
Carcinoma, Neuroendocrine0202320231.0low000003
Carcinoma, Non-Small Cell Lung01998202214.0low001001
Carcinoma, Non-Small-Cell Lung01998202214.0low001001
Carcinoma, Small Cell Lung0201420225.0low000012
Carcinoma, Squamous Cell01998200821.0low001100
Cell Transformation, Neoplastic02007201214.5low000220
Cholera Infantum01984201125.5low011110
Chronic Hepatitis02003200321.0low000100
Chronic Kidney Failure01985198539.0low010000
Cirrhosis, Liver02003200321.0low000100
Colonic Neoplasms01992201720.0low007450
Colonic Polyps02001201315.3low000120
Colorectal Cancer01993201720.4low0071140
Colorectal Neoplasms01993201720.4low0071140
Coma01988198836.0low010000
Common Bile Duct Neoplasms01990199034.0low001000
Condition, Preneoplastic02000200422.0low001100
Curling Ulcer01981199337.5low074000
Diarrhea01995199529.0low001000
Diathesis02000200024.0low001000
Digestive System Diseases01988198836.0low010000
Digestive System Disorders01988198836.0low010000
Disease Exacerbation0202320231.0low000002
Disease Models, Animal02011201212.5low000020
Duodenal Ulcer01981199337.5low074000
Dyspepsia01994200027.0low002000
Esophageal Neoplasms02008200816.0low000100
Esophagitis01992199232.0low001000
Gastric Ulcer01984198539.3low030000
Gastrin-Producing Tumor01988201431.9low076010
Gastrinoma01988201431.9low076010
Gastritis01985198937.0low020000
Gastritis, Atrophic01985198937.0low020000
Gastroduodenal Ulcer01984201128.0low013010
Glioblastoma0202320231.0low000001
Helicobacter Infections01993200325.3low005500
Hepatitis, Chronic02003200321.0low000100
Hepatitis, Viral, Human02003200321.0low000100
Hyperparathyroidism01986198638.0low010000
Hyperplasia01986202318.4low021212
Hypertrophy01999199925.0low001000
Indigestion01994200027.0low002000
Infections, Helicobacter01993200325.3low005500
Insulinoma01998199826.0low001000
Invasiveness, Neoplasm02013201311.0low000010
Island Cell Tumor01987198737.0low010000
Kidney Failure01998199826.0low001000
Kidney Failure, Chronic01985198539.0low010000
Leucocythaemia02005200519.0low000100
Leukemia02005200519.0low000100
Liver Cirrhosis02003200321.0low000100
Liver Neoplasms01986201726.3low031020
Lung Neoplasms01988202312.2low021025
Metastase02003201217.7low000210
Multiple Primary Neoplasms02000200024.0low001000
Neoplasm Metastasis02003201217.7low000210
Neoplasms0200620219.8low000211
Neuroendocrine Tumors0202320231.0low000003
Ovarian Neoplasms01993199331.0low001000
Pancreatic Neoplasms01989200828.5low053400
Parathyroid Neoplasms01986198638.0low010000
Peptic Ulcer01984201128.0low013010
Pituitary Neoplasms01987199533.0low011000
Precancerous Conditions02000200422.0low001100
Pregnancy01989199333.3low012000
Prostatic Neoplasms, Castration-Resistant0202320231.0low000002
Rectal Neoplasms01992199331.5low002000
Renal Insufficiency01998199826.0low001000
Sensitivity and Specificity01998202114.5low001001
Small Cell Lung Carcinoma0201420225.0low000012
Stomach Neoplasms01984202221.4low012311
Stomach Ulcer01984198539.3low030000
Viral Hepatitis, Human02003200321.0low000100
Zollinger-Ellison Syndrome01980199836.5low0106000

Pharmacokinetics (1)

ArticleYear
The pharmacokinetics and pharmacodynamics of progastrin-derived peptides.
Danish medical bulletin, , Volume: 50, Issue:4
2003

Dosage (2)

ArticleYear
Modulation of murine peritoneal macrophage functions by gastrin.
Peptides, , Volume: 17, Issue:2
1996
Similar acid stimulatory potencies of synthetic human big and little gastrins in man.
The Journal of clinical investigation, , Volume: 73, Issue:5
1984